Brooks Laboratories Limited - Asset Resilience Ratio

Latest as of September 2025: 1.29%

Brooks Laboratories Limited (BROOKS) has an Asset Resilience Ratio of 1.29% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read Brooks Laboratories Limited (BROOKS) total liabilities for a breakdown of total debt and financial obligations.

Liquid Assets

Rs18.03 Million
≈ $195.02K USD Cash + Short-term Investments

Total Assets

Rs1.40 Billion
≈ $15.13 Million USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (2009–2025)

This chart shows how Brooks Laboratories Limited's Asset Resilience Ratio has changed over time. See Brooks Laboratories Limited (BROOKS) net assets for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Brooks Laboratories Limited's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see BROOKS market cap.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents Rs299.00K 0.02%
Short-term Investments Rs17.73 Million 1.27%
Total Liquid Assets Rs18.03 Million 1.29%

Asset Resilience Insights

  • Limited Liquidity: Brooks Laboratories Limited maintains only 1.29% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Brooks Laboratories Limited Industry Peers by Asset Resilience Ratio

Compare Brooks Laboratories Limited's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Changchun High & New Technology Industries Group Inc
SHE:000661
Drug Manufacturers - Specialty & Generic 3.73%
Yuhan Corp.
KO:000100
Drug Manufacturers - Specialty & Generic 0.99%
Tasly Pharmaceutical Group Co Ltd
SHG:600535
Drug Manufacturers - Specialty & Generic 9.09%
Zhejiang Hisun Pharmaceutical Co Ltd
SHG:600267
Drug Manufacturers - Specialty & Generic 0.02%
Zhejiang Jiuzhou Pharm Co Ltd
SHG:603456
Drug Manufacturers - Specialty & Generic 0.01%
Shanghai Yizhong Pharmaceutical Co Ltd
SHG:688091
Drug Manufacturers - Specialty & Generic 26.36%
Jiangsu Kanion Pharmaceutical Co Ltd
SHG:600557
Drug Manufacturers - Specialty & Generic 0.29%
Cronos Group Inc
TO:CRON
Drug Manufacturers - Specialty & Generic 69.94%

Annual Asset Resilience Ratio for Brooks Laboratories Limited (2009–2025)

The table below shows the annual Asset Resilience Ratio data for Brooks Laboratories Limited.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-03-31 1.90% Rs23.45 Million
≈ $253.55K
Rs1.24 Billion
≈ $13.38 Million
-0.68pp
2024-03-31 2.58% Rs23.33 Million
≈ $252.31K
Rs904.45 Million
≈ $9.78 Million
+1.32pp
2023-03-31 1.26% Rs13.78 Million
≈ $149.05K
Rs1.10 Billion
≈ $11.85 Million
-0.69pp
2022-03-31 1.94% Rs38.10 Million
≈ $412.04K
Rs1.96 Billion
≈ $21.19 Million
+0.62pp
2021-03-31 1.32% Rs21.41 Million
≈ $231.50K
Rs1.62 Billion
≈ $17.53 Million
+0.35pp
2020-03-31 0.97% Rs15.28 Million
≈ $165.23K
Rs1.58 Billion
≈ $17.07 Million
-1.01pp
2019-03-31 1.98% Rs33.17 Million
≈ $358.76K
Rs1.68 Billion
≈ $18.16 Million
+1.41pp
2018-03-31 0.56% Rs9.67 Million
≈ $104.62K
Rs1.73 Billion
≈ $18.67 Million
+0.38pp
2017-03-31 0.18% Rs2.86 Million
≈ $30.96K
Rs1.63 Billion
≈ $17.64 Million
+0.12pp
2010-03-31 0.05% Rs200.00K
≈ $2.16K
Rs372.57 Million
≈ $4.03 Million
-0.01pp
2009-03-31 0.06% Rs200.00K
≈ $2.16K
Rs321.19 Million
≈ $3.47 Million
--
pp = percentage points

About Brooks Laboratories Limited

NSE:BROOKS India Drug Manufacturers - Specialty & Generic
Market Cap
$17.83 Million
Rs1.65 Billion INR
Market Cap Rank
#25384 Global
#1413 in India
Share Price
Rs55.98
Change (1 day)
-4.89%
52-Week Range
Rs37.11 - Rs161.50
All Time High
Rs194.97
About

Brooks Laboratories Limited provides contract development and manufacturing services for pharmaceutical companies in India and internationally. The company's product portfolio includes liquid injection ampoules and vials, dry powder injection vials, lyophilized injections, eye/ear drops, and nasal drops; B-Lactam and cephalosporin tablets, dry powder syrups, and injections; general, liquid, and d… Read more